

BPC-157 5mg
Pentadecapeptide studied for tissue repair, tendon healing and gut integrity pathways.
Aetheris Labs — Synthesis Division
High-purity research peptides, synthesized under ISO-class cleanroom conditions and verified by third-party analytical labs. Batch COA with every vial.
01 — Catalog
Every batch is HPLC and mass-spec verified. Certificates of analysis ship with each order.
22 compounds


Pentadecapeptide studied for tissue repair, tendon healing and gut integrity pathways.


Thymosin Beta-4 fragment researched for cell migration, angiogenesis and wound repair.


GHRH analog (no DAC) investigated for pulsatile growth hormone release kinetics.


Selective ghrelin receptor agonist studied for GH selectivity without cortisol elevation.


Triple GIP/GLP-1/glucagon receptor agonist researched for metabolic signaling and weight regulation.


Triple GIP/GLP-1/glucagon receptor agonist researched for metabolic signaling and weight regulation.


Triple GIP/GLP-1/glucagon receptor agonist researched for metabolic signaling and weight regulation.


Dual GIP/GLP-1 receptor agonist studied for glycemic control and appetite regulation pathways.


Dual GIP/GLP-1 receptor agonist studied for glycemic control and appetite regulation pathways.


Dual GIP/GLP-1 receptor agonist studied for glycemic control and appetite regulation pathways.


Recombinant 191-amino-acid somatropin, researched for growth hormone axis and IGF-1 signaling.


Recombinant 191-amino-acid somatropin, researched for growth hormone axis and IGF-1 signaling.


Copper tripeptide complex studied for collagen synthesis, skin remodeling and wound healing.


Copper tripeptide complex studied for collagen synthesis, skin remodeling and wound healing.


Mitochondrial-derived peptide researched for metabolic regulation and exercise capacity.


Klow blend researched for anti-inflammatory and recovery pathways.


Mitochondria-targeted tetrapeptide studied for cellular energy and oxidative stress.


Melanocortin receptor agonist researched for melanogenesis pathways.


Melanocortin receptor agonist researched for melanogenesis pathways.


Nicotinamide adenine dinucleotide studied for cellular metabolism and sirtuin activity.


Tripeptide antioxidant researched for redox balance and detoxification pathways.


Bacteriostatic water (0.9% benzyl alcohol) for research reconstitution.
02 — Standard
We treat every microgram like it matters — because in research, it does. Synthesis, purification and lyophilization run under one documented chain of custody.
Purity confirmed by high-performance liquid chromatography on every synthesis batch.
Molecular identity validated against reference standards before release.
Lyophilized and dispatched in temperature-controlled packaging.
Full certificate of analysis, endotoxin screen and lot traceability included.
Lab 04 — Analytical Suite
99%+
03 — Verification
Every batch is independently assayed by Janoshik Analytical. Measured content is published against the labelled claim — no underfilled vials, ever.
| Compound | Batch | Labelled | Measured | Purity | Report № | Date |
|---|---|---|---|---|---|---|
Hospira Bac Water 30mlJanoshik Analytical | BW-2607-A | 30ml, 0.9% benzyl alcohol | 30ml, 0.91% benzyl alcohol | 99.99% (USP) | JSH-51360 | 2026-07-20 |
Glutathione 600mgJanoshik Analytical | GL-2607-A | 600mg | 611.3mg | 99.59% | JSH-51353 | 2026-07-18 |
NAD+ 500mgJanoshik Analytical | ND-2607-A | 500mg | 508.7mg | 99.52% | JSH-51352 | 2026-07-18 |
MT-2Janoshik Analytical | M2-2607-A | 10mg | 10.31mg | 99.71% | JSH-51348 | 2026-07-18 |
MT-1Janoshik Analytical | M1-2607-A | 10mg | 10.24mg | 99.66% | JSH-51347 | 2026-07-18 |
SS31 60mgJanoshik Analytical | SS-2607-A | 60mg | 61.42mg | 99.38% | JSH-51342 | 2026-07-16 |
KlowJanoshik Analytical | KL-2607-A | 10mg | 10.28mg | 99.57% | JSH-51341 | 2026-07-16 |
MOTS-c 40mgJanoshik Analytical | MC-2607-A | 40mg | 41.06mg | 99.44% | JSH-51340 | 2026-07-16 |
GHK-Cu 50mgJanoshik Analytical | CU-2606-A | 50mg | 51.34mg | 99.58% | JSH-51255 | 2026-06-20 |
GHK-Cu 100mgJanoshik Analytical | CU-2606-B | 100mg | 102.18mg | 99.66% | JSH-51256 | 2026-06-20 |
Retatrutide 10mgJanoshik Analytical | RT-2606-A | 10mg | 10.42mg | 99.61% | JSH-51208 | 2026-06-14 |
Retatrutide 40mgJanoshik Analytical | RT-2606-C | 40mg | 41.15mg | 99.72% | JSH-51210 | 2026-06-14 |
Retatrutide 20mgJanoshik Analytical | RT-2606-B | 20mg | 20.87mg | 99.48% | JSH-51209 | 2026-06-14 |
HGH (Somatropin) 18iuJanoshik Analytical | GH-2606-B | 18iu | 18.6iu (6.21mg) | 99.12% | JSH-51103 | 2026-06-02 |
HGH (Somatropin) 36iuJanoshik Analytical | GH-2606-A | 36iu | 37.1iu (12.36mg) | 98.94% | JSH-51102 | 2026-06-02 |
Tirzepatide 40mgJanoshik Analytical | TZ-2605-C | 40mg | 40.92mg | 99.81% | JSH-51046 | 2026-05-28 |
Tirzepatide 20mgJanoshik Analytical | TZ-2605-B | 20mg | 20.64mg | 99.67% | JSH-51045 | 2026-05-28 |
Tirzepatide 10mgJanoshik Analytical | TZ-2605-A | 10mg | 10.31mg | 99.55% | JSH-51044 | 2026-05-28 |
CJC-1295Janoshik Analytical | CJ-2605-A | 5mg | 5.14mg | 99.52% | JSH-50983 | 2026-05-06 |
IpamorelinJanoshik Analytical | IP-2605-A | 5mg | 5.09mg | 99.61% | JSH-50984 | 2026-05-06 |
TB-500 5mgJanoshik Analytical | TB-2604-A | 5mg | 5.18mg | 99.27% | JSH-50872 | 2026-04-19 |
BPC-157 5mgJanoshik Analytical | BP-2604-A | 5mg | 5.21mg | 99.43% | JSH-50871 | 2026-04-19 |
Verify any report number directly with the issuing laboratory. Method: HPLC / MS unless noted.